Plain-English translation of NCT07111637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests whether a computer software tool called icobrain ms can help doctors spot changes in your brain more accurately when they review your MRI scans. The software is designed to work alongside radiologists to catch problems that might be missed during standard scan review, so your MS treatment can be adjusted more effectively if needed.
Doctors need MRI scans to see if MS treatment is working and to decide whether to change medications. However, human radiologists can miss small changes in the brain due to fatigue, time pressure, and differences in how scans are taken across hospitals. This study aims to show that AI assistance can catch three to four times more of these important changes, leading to better treatment decisions for MS patients.
You likely qualify if…
You likely don't qualify if…
You would have your routine MRI brain scan as usual. The difference is that your scan would be analyzed in two ways: first by a radiologist as normal, and second with help from the AI software icobrain ms. The doctors would then compare both readings to see if the AI-assisted approach catches more changes in your brain and helps them make better decisions about your MS treatment.
AI-generated summary from trial data · Aug 16, 2026 · Not medical advice
United Kingdom